OHAS

AcronymDefinition
OHASOff Hook Alarm System (telecommunications industry)
OHASObsidian Hydration Analysis Service
OHASOffaly Historical and Archaeological Society (Ireland)
OHASOccupational Health Automated System
OHASOcccupational Health Advisory Service (UK)
OHASOffice of HIV/AIDS Surveillance
OHASOutpatient Hospital Allowance Schedule (Anthem)
References in periodicals archive ?
The characteristics of the two samples were quite similar as would be expected given significant overlap among diabetes patients taking OHAs and statins.
We found that the GDR for multisource OHAs was 99 percent in every LIS support group as well as for non-LIS enrollees.
In 2008, brand coverage for multisource statins was comparable to OHAs (i.e., brands in such classes were excluded on virtually all formularies), resulting in very low usage of these brands.
We carefully selected measures to capture differences in diabetes severity, complications, and comorbidities that could reasonably be expected to differentially influence need for OHAs and statins across the four study cohorts.
Table A1: Regression Models for Adjusted Differences in Mean Annual Days Supply for Oral Hypoglycemic Agents (OHAs) Filled by Low-Income Support (LIS) Category in 2008.
Table A2: Regression Models for Adjusted Differences in Mean Generic Dispensing Rate (GDR) for Oral Hypoglycemic Agents (OHAs) Filled by Low-Income Support (LIS) Category in 2008.
Table A3: Regression Models for Adjusted Differences in Mean Annual Number of Fills for Oral Hypoglycemic Agents (OHAs) Filled by Low-Income Support (LIS) Category in 2008.
Table A4: Regression Models for Adjusted Differences in Mean Days Supply per Fill for Oral Hypoglycemic Agents (OHAs) Filled by Low-Income Support (LIS) Category in 2008.
Table A5: Regression Models for Adjusted Differences in Mean Cost per 30-Day Fill for Oral Hypoglycemic Agents (OHAs) Filled by Low-Income Support (LIS) Category in 2008.
Table A6: Regression Models for Adjusted Differences in Mean Annual Cost for Oral Hypoglycemic Agents (OHAs) Filled by Low-Income Support (LIS) Category in 2008.
We found little association between cost sharing and aggregate OHA and statin use.
Higher generic and brand copays had little association with OHA and statin use among LIS recipients.